The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo
Keywords: AC; adenylyl cyclase; AS; Angeli's salt; β1-AR; β1-adrenoceptor; CGRP; calcitonin gene-related peptide; CK; creatine kinase; DEA/NO; diethylamine NONOate; DOB; dobutamine; DRC; dose-response curve; HF; heart failure; HNO; nitroxyl; I-R; ischaemia-